Regulon

Regulon: R-1432

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
200.85604810Pr-151Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
23196 ENSG00000048828 FAM120A Q9NZB2
51742 ENSG00000054267 ARID4B Q4LE39
23198 ENSG00000068878 PSME4 Q14997
5351 ENSG00000083444 PLOD1 Q02809
25 ENSG00000097007 ABL1 P00519
11252 ENSG00000100266 PACSIN2 B0QYG7
23268 ENSG00000107554 DNMBP Q6XZF7
23469 ENSG00000118482 PHF3 Q92576
8795 ENSG00000120889 TNFRSF10B O14763
206358 ENSG00000123643 SLC36A1 Q7Z2H8
59269 ENSG00000127124 HIVEP3 Q5T1R4
58190 ENSG00000144579 CTDSP1 Q9GZU7
5784 ENSG00000152104 PTPN14 Q15678
8888 ENSG00000160294 MCM3AP O60318
824 ENSG00000162909 CAPN2 P17655
3673 ENSG00000164171 ITGA2 P17301
25836 ENSG00000164190 NIPBL Q6KC79
9790 ENSG00000165733 BMS1 Q14692
558 ENSG00000167601 AXL P30530
9792 ENSG00000179833 SERTAD2 Q14140

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
REBASTINIBABL1Small moleculeINHIBITORTyrosine-protein kinase ABL inhibitor20
UMBRALISIBPIK3CDSmall moleculeINHIBITORTyrosine-protein kinase ABL inhibitor40
RADOTINIBABL1Small moleculeINHIBITORBcr/Abl fusion protein inhibitor30
DASATINIBABL1Small moleculeINHIBITORPlatelet-derived growth factor receptor beta inhibitor42
SARACATINIBABL1Small moleculeINHIBITORTyrosine-protein kinase SRC inhibitor30
NILOTINIB HYDROCHLORIDE MONOHYDRATEABL1Small moleculeINHIBITORBcr/Abl fusion protein40
OLVEREMBATINIBABL1Small moleculeINHIBITORBcr/Abl fusion protein inhibitor20
BEMCENTINIBAXLSmall moleculeINHIBITORTyrosine-protein kinase receptor UFO inhibitor20
IMATINIB MESYLATEABL1Small moleculeINHIBITORBcr/Abl fusion protein43
ASCIMINIBABL1Small moleculeINHIBITORTyrosine-protein kinase ABL inhibitor30
BOSUTINIBABL1Small moleculeINHIBITORBcr/Abl fusion protein42
BAFETINIBLYNSmall moleculeINHIBITORTyrosine-protein kinase ABL inhibitor20
TIGATUZUMABTNFRSF10BAntibodyAGONISTTumor necrosis factor receptor superfamily member 10B agonist30
NILOTINIBABL1Small moleculeINHIBITORBcr/Abl fusion protein40
IMATINIBABL1Small moleculeINHIBITORBcr/Abl fusion protein43
VODOBATINIBABL1Small moleculeINHIBITORTyrosine-protein kinase ABL inhibitor20
UMBRALISIB TOSYLATECSNK1ESmall moleculeINHIBITORTyrosine-protein kinase ABL inhibitor40
XL-228ABL1Small moleculeINHIBITORTyrosine-protein kinase ABL inhibitor10
GILTERITINIB FUMARATEAXLSmall moleculeINHIBITORTyrosine-protein kinase receptor FLT3 inhibitor40
KW-2449AURKBSmall moleculeINHIBITORTyrosine-protein kinase ABL inhibitor10
GILTERITINIBAXLSmall moleculeINHIBITORTyrosine-protein kinase receptor UFO inhibitor40
PONATINIBABL1Small moleculeINHIBITORBcr/Abl fusion protein inhibitor42
FLUMATINIBABL1Small moleculeINHIBITORTyrosine-protein kinase ABL inhibitor30
CONATUMUMABTNFRSF10BAntibodyAGONISTTumor necrosis factor receptor superfamily member 10B agonist20
BPI-9016AXLSmall moleculeINHIBITORTyrosine-protein kinase receptor UFO inhibitor10
SKLB1028ABL1Small moleculeINHIBITORTyrosine-protein kinase ABL inhibitor30
DULANERMINTNFRSF10BProteinAGONISTTRAIL receptor-1 agonist20
AT-9283AURKBSmall moleculeINHIBITORTyrosine-protein kinase JAK3 inhibitor20
VATELIZUMABITGA2AntibodyANTAGONISTIntegrin alpha-2 antagonist20
LEXATUMUMABTNFRSF10BAntibodyAGONISTTumor necrosis factor receptor superfamily member 10B agonist10
DROZITUMABTNFRSF10BAntibodyAGONISTTumor necrosis factor receptor superfamily member 10B agonist20
PONATINIB HYDROCHLORIDEABL1Small moleculeINHIBITORBcr/Abl fusion protein inhibitor40
REGORAFENIBKDRSmall moleculeINHIBITORTyrosine-protein kinase TIE-2 inhibitor42
AZD-0424ABL1Small moleculeINHIBITORTyrosine-protein kinase SRC inhibitor10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1432

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs